![cover image](https://wikiwandv2-19431.kxcdn.com/_next/image?url=https://upload.wikimedia.org/wikipedia/commons/thumb/a/a7/Roussel-UCLAF-AncienSi%25C3%25A8ge.jpg/640px-Roussel-UCLAF-AncienSi%25C3%25A8ge.jpg&w=640&q=50)
Roussel Uclaf
French pharmaceutical company / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Roussel Uclaf?
Summarize this article for a 10 year old
Roussel Uclaf S.A. was a French pharmaceutical company and one of several predecessor companies of today's Sanofi.
![]() Former headquarters of Roussel-Uclaf, 35 Boulevard des Invalides, 7th arrondissement of Paris | |
Company type | Public (Société anonyme) |
---|---|
Industry | Pharmaceutical |
Founded | Paris, France (1911 (1911)) Institut de Sérothérapie Hémopoïétique ISH (1920) Usines Chimiques des Laboratoires Français UCLAF (1928) Société Française de la Pénicilline SOFRAPEN (1947) (Roussel-Uclaf, S.A. incorporated 1961) |
Founder | Gaston Roussel |
Defunct | September 30, 1997 (September 30, 1997)[1] |
Fate | Acquired |
Successor | Hoechst AG (Hoechst Marion Roussel) |
Headquarters | Paris, France (1911–1995) Romainville, France (1995–1997)[2] |
Area served | Worldwide |
Key people | Gaston Roussel (CEO, 1911–1947) Jean-Claude Roussel (CEO, 1961–1972) Jacques Machizaud (CEO, 1974–1981) Édouard Sakiz (CEO, 1981–1993) Ernst-Günter Afting (CEO, 1994–1995) Jean-Pierre Godard (CEO, 1995–1997) |
Products | Hemostyl (erythropoietin, horse serum) Rubiazol (carboxysulfamidochrysoidine) Rythmodan (disopyramide) Decis (deltamethrin) Surgam (tiaprofenic acid) Claforan (cefotaxime sodium) Mifegyne (mifepristone, RU-486) Anandron (nilutamide) |
Revenue | ![]() |
![]() | |
Number of employees | 15,673 worldwide (1992)[4] 8,409 in France (1992)[4] 6,533 in France (1996)[5] |
It was the second largest French pharmaceutical company[6] before it was acquired by Hoechst AG of Frankfurt, Germany in 1997, with pharmaceutical operations combined into the Hoechst Marion Roussel (HMR) division in the United States. Roussel Uclaf's agrochemical operations had been transferred to Hoechst Schering AgrEvo GmbH in 1994.
HMR subsequently merged in 1999 with Rhône-Poulenc to form Aventis, which then merged in 2004 with Sanofi-Synthélabo to form Sanofi-Aventis, which was since renamed Sanofi. Hoechst Schering AgrEvo merged in 1999 with Rhône-Poulenc's agrochemical division to form Aventis CropScience, which was acquired by Bayer AG in 2002 and combined with Bayer's agrochemical division to form Bayer CropScience.